MassGeneral Institute for Neurodegenerative Disease

Translating today's discoveries into tomorrow's cures

Facebook icon Twitter Icon

News page banner

First Human Trial for ALS Treatment Candidate AT-1501 Begins Dosing

12/03/2018 -  ALS News Today covers clinical trial led by MGH physician Merit Cudkowicz. “We are excited to work closely with Anelixis to accelerate bringing AT-1501 to people with ALS,” said Merit Cudkowicz, director of the Healey Center for ALS at Massachusetts General Hospital, and chief medical officer for ALS Finding a Cure. Read the full article.